Profiles

Keywords
Last Name
Institution

Connection

Search Results to Robin Jones

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Jones, Robin

Item TypeName
Concept Antibodies, Monoclonal
Concept Antibodies, Monoclonal, Humanized
Academic Article Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
Academic Article Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response.
Academic Article Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside.
Academic Article Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.
Academic Article Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Academic Article Olaratumab for the treatment of soft-tissue sarcoma.
Academic Article Olaratumab in soft tissue sarcoma - Current status and future perspectives.
Academic Article A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
Academic Article Negative phase III trials announce the need for biomarkers in sarcoma.
Academic Article Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Academic Article Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.
Academic Article Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma.
Academic Article A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Academic Article Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.

Search Criteria
  • Antibodies Monoclonal